Article Text

Download PDFPDF
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: authors’ response
  1. Surya P Bhatt1,
  2. George R Washko2,
  3. Mark T Dransfield1,
  4. Jessica C Sieren3,
  5. John D Newell Jr3,
  6. Eric A Hoffman3
  1. 1 Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  2. 2 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
  3. 3 Department of Radiology, University of Iowa, Iowa City, Iowa, USA
  1. Correspondence to Dr Surya P Bhatt, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720, 2nd Avenue South, Birmingham, AL 35294, USA; spbhatt{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We thank Dr Miller for his comments1 on our recent article.2 While we agree that age is an important factor in this longstanding controversy, we would like to debate some of the points he makes. First, contrary to his assertions, strong relationships have been shown between CT measures of emphysema and pathological findings.3 While there has, in the past, been discussion regarding the ‘best’ Hounsfield Unit (HU) threshold to define CT emphysema, our use of −950 HU, correlating with more severe disease, has been used widely to demonstrate the power of CT-based density metrics in identifying COPD phenotypes, monitoring longitudinal changes and reducing the population size needed to power pharmaceutical studies.4 ,5 Second, while we agree with Dr Miller that age may impact the CT-based emphysema score, the effect size is considerably smaller than suggested. Recent data from COPDGene examining normal subjects with a similar age range as our study, with identical scanner protocols, was unable to detect a significant age effect.6 Analyses of data from the Multi-Ethnic Study of Atherosclerosis Lung study, which included a much larger and older population, (n=854) showed a small age effect (0.2% for every 10 years) on CT-emphysema.7 In another large multicentre study, Coxson et al 8 noted that the progression of CT-emphysema with advancing age is low. …

View Full Text


  • Contributors SPB and EAH drafted the initial response. All authors reviewed the manuscript and added critical information.

  • Funding COPDGene is supported by NIH Grant Numbers U01 HL089897 and U01 HL089856.

  • Competing interests MTD received consultancy fees from Boehringer Ingelheim and GlaxoSmithKline. JDN received consultancy fees from VIDA Diagnostics. EAH is the founder of, and owns stocks in, VIDA Diagnostics.

  • Ethics approval IRBs at 21 academic medical centres.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles